Sandeep J. Khandar, MD, FACS
Dr. Sandeep J. Khandar is a cardiothoracic and thoracic surgeon and member of the Virginia Cancer Specialists Physicians Group which practices within the INOVA Health System in Northern Virginia. Board-certified in Cardiothoracic Thoracic and General Surgery, he has a special interest in the management of lung cancer, malignant pleural mesothelioma, and other thoracic malignancies using minimally invasive surgical techniques.[1]
Dr. Khandar appreciates the many advantages of working with a collaborative multidisciplinary team that relies on cutting-edge technology and advances in oncology care to provide the best possible outcomes for their patients.
Education and Career
Dr. Khandar attended Northwestern University in Chicago, Illinois for both his undergraduate education and medical education, earning a degree in Biomedical Engineering as well as his medical degree. He completed an internship and residency in General Surgery at the University of Texas Health Science Center at San Antonio, where he was named the administrative chief resident. He also completed a fellowship in Cardiothoracic Surgery at Duke University, specializing in Thoracic Surgery and Thoracic Oncology.[1]
Dr. Khandar has been practicing in Northern Virginia for over ten years and has been honored with many awards.
Professional Memberships and Activities
Dr. Khandar is actively involved in several professional medical organizations, including:
- Cardiothoracic Surgery Network
- General Thoracic Surgical Club
- International Society for Minimally Invasive Cardiothoracic Surgery
- Southern Thoracic Surgical Association
- The Society of Thoracic Surgeons
He has served and continues to serve in leadership roles within the hospitals where he practices, and works to facilitate the growth and development of innovations in surgical lung cancer treatment. He also sits on the advisory boards of leading international medical device companies relative to thoracic surgery.[1]
Research
Dr. Khandar believes that research and clinical trials are vital to continued progress in providing advanced cancer treatments and bringing promising new protocols to patients diagnosed with challenging diagnoses. He is actively involved in studies being conducted by Virginia Cancer Specialists’ Research Facility for Phase 1 Clinical Trials, which is the largest of its kind in the Northern Virginia area.
His publications include:[1]
NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the United States. Erik E. Folch, MD, MSc, Mark R. Bowling, MD, Michael A. Pritchett, DO, MPH, Jennifer J. Wolvers, BSc, Sandeep J. Khandhar, MD for the NAVIGATE Study Investigators: January 14, 2022DOI:https://doi.org/10.1016/j.jtho.2021.12.008
Electromagnetic Navigation Bronchoscopy for Peripheral Pulmonary Lesions: One-Year Results of the Prospective, Multicenter NAVIGATE Study. Erik E Folch 1, Michael A Pritchett 2, Michael A Nead 3, Mark R Bowling 4, Septimiu D Murgu 5, William S Krimsky 6, Boris A Murillo 7, Gregory P LeMense 8, Douglas J Minnich 9, Sandeep Bansal 10, Blesilda Q Ellis 11, Amit K Mahajan 12, Thomas R Gildea 13, Rabih I Bechara 14, Eric Sztejman 15, Javier Flandes 16, Otis B Rickman 17, Sadia Benzaquen 18, D Kyle Hogarth 19, Philip A Linden 20, Momen M Wahidi 21, Jennifer S Mattingley 22, Kristin L Hood 23, Haiying Lin 23, Jennifer J Wolvers 23, Sandeep J Khandhar 12; PMID: 30476574 DOI: 10.1016/j.jtho.2018.11.013
Implementing a thoracic enhanced recovery with ambulation after surgery program: key aspects and challenges. Marissa A Mayor 1, Sandeep J Khandhar 1, Joby Chandy 1, Hiran C Fernando 1. PMID: 30505568 PMCID: PMC6258653 DOI: 10.21037/jtd.2018.10.106
